Inside the $2 Billion Moscow Telemedicine Fraud Case: What Florida Pharmacy Owners, Telehealth Doctors, and Billing Operators Need to Know

Inside the $2 Billion Moscow Telemedicine Fraud Case: What Florida Pharmacy Owners, Telehealth Doctors, and Billing Operators Need to Know

The Justice Department just dropped three more sentences in one of the largest telemedicine fraud prosecutions in U.S. history. On May 19, 2026, U.S. District Judge William F. Kuntz II sentenced Anthony Santamaria to 10 years in federal prison for his role in a Moscow-based scheme that billed nearly $2 billion in fraudulent prescriptions through more than 75 pharmacies across the country. Co-defendants Hershel Tsikman and Hafizullah Ebady were sentenced to 120 months and 97 months earlier in May. Three additional defendants are awaiting sentencing. The alleged leader, Brian Sutton, remains a fugitive abroad.

If you are involved in any U.S.-side piece of a telehealth, pharmacy, or DME operation right now, this case is a roadmap for how federal prosecutors are going to come after you next.

The sentencing numbers are staggering. The more important story is the investigative methodology that reached every U.S.-based operator who touched the scheme.

What Actually Happened

Between 2017 and 2022, the defendants ran what DOJ describes as a sophisticated, international criminal organization. Call centers — initially based in Utah and later operated from Russia — contacted Americans enrolled with private insurers and offered free medications. No medical exams. No legitimate evaluation of medical necessity. The defendants then generated prescriptions in the names of recruited doctors and nurse practitioners, often without any actual telemedicine visit occurring.

Behind the script: the defendants bought up dozens of brick-and-mortar pharmacies through straw owners in Brooklyn, Staten Island, Manhattan, Long Island, New Jersey, Pennsylvania, Texas, Michigan, and Alabama. Moscow-based billers were trained to remotely submit electronic reimbursement requests through those pharmacies. The numbers are staggering: $1.97 billion in fraudulent prescriptions submitted, $758 million actually paid out by private insurers.

To launder the proceeds, the defendants used shell companies, straw owners, encrypted communications, and wired millions of dollars overseas. Tsikman alone reportedly coordinated the laundering through more than 30 pharmacies.

What the Government Is Actually Building

This case is being prosecuted out of the Eastern District of New York, but the implications stretch well beyond Brooklyn.

The DOJ created the National Fraud Enforcement Division in April 2026. It is focused on healthcare fraud, telehealth, and pandemic-era schemes, and it pulls together resources from the Criminal Division, FBI, HHS-OIG, and U.S. Attorney's Offices across the country. The Moscow telemedicine prosecution is one of its first marquee wins. Expect more.

Federal prosecutors are no longer just chasing the kingpins. The sentencings of Santamaria, Tsikman, and Ebady show DOJ is willing to put significant prison time on the middle layer: the billers, the logistics coordinators, the money movers, and the boots-on-the-ground pharmacy managers. These are not the architects cutting deals with Russian call centers. They are the U.S.-based operators making the back-end work.

The investigative methodology in these cases reaches downstream. DOJ pulls third-party billing records, follows the money through shell entities, identifies pharmacies with billing anomalies, and then works outward to every person who touched the operation. If you owned one of those pharmacies in a nominee capacity, signed billing affidavits, processed reimbursements, or recruited the prescribing physicians, you are exposed.

$1.97 billion billed. $758 million paid. The money-laundering charges, the shell companies, and the 30-pharmacy network show how far the government will trace the proceeds.

The Florida Angle

The Southern District of Florida has been the epicenter of telemedicine-linked fraud prosecutions for years. The 2025 National Health Care Fraud Takedown charged dozens of South Florida defendants across schemes involving durable medical equipment, orthotic braces, COVID-era billing, and sober homes. The same pattern shows up: telehealth shells, kickback arrangements, and pharmacies or DME suppliers feeding the billing pipeline.

For South Florida federal criminal defense, the Moscow telemedicine case matters for one reason. It sets a sentencing benchmark for what comparable U.S.-based defendants will face. A 10-year sentence for a back-office biller in EDNY tells you exactly what the government will argue against a similarly situated SDFL defendant: massive loss amounts, sophisticated means enhancements, role adjustments, and money laundering counts stacked on top of the underlying healthcare fraud.

SDFL has been the epicenter of telehealth fraud prosecutions for years. The Moscow case sets the sentencing benchmark for what Florida defendants will face.

Exposure: The Statutes and the Math

The defendants in the Moscow case were prosecuted under a familiar federal stack:

18 U.S.C. § 1347 (health care fraud). 10-year max per count, 20 years if serious bodily injury results, life if death results.

18 U.S.C. § 1349 (conspiracy to commit health care or wire fraud). Same penalties as the underlying offense.

18 U.S.C. § 1343 (wire fraud). 20-year max per count, 30 years if affecting a financial institution.

42 U.S.C. § 1320a-7b (Anti-Kickback Statute). 10-year max per count, plus mandatory program exclusion.

18 U.S.C. §§ 1956 and 1957 (money laundering). 20-year and 10-year maxes respectively.

The real driver of sentencing exposure is the loss amount under U.S.S.G. § 2B1.1. At $1.97 billion in fraudulent billings and $758 million in actual payments, the loss table alone adds 30 levels to the base offense level. Add sophisticated means, mass-marketing, money laundering, leadership role, and the recommended guideline range pushes well past life-equivalent numbers before any cooperation or variance arguments come in.

For a Florida pharmacy owner facing similar conduct on a smaller scale, even a fraction of that loss math gets serious fast. A $5 million loss alone adds 18 levels. A $25 million loss adds 22.

The Mistakes People Are Making Right Now

The same patterns appear in every healthcare fraud investigation.

Talking to agents without counsel. The HHS-OIG agents knocking on your door are friendly until they are not. Anything you say becomes part of the file. Anything inconsistent becomes a § 1001 false statements count.

Producing documents without a litigation strategy. Once you get a federal grand jury subpoena or an administrative subpoena from HHS-OIG, every document you produce shapes the indictment. Producing without privilege review, scope objections, or strategy is how clients hand the government their case.

Assuming the investigation is not serious because no charges have been filed. The Moscow defendants were under investigation for years before the indictment unsealed. Federal healthcare fraud cases are slow, methodical, and final. By the time you see a federal target letter, the U.S. Attorney's Office has been building the case for 18 to 36 months.

Cooperating without understanding the proffer terms. Walking into a proffer without a pre-negotiated proffer agreement and a clear-eyed read on whether the government wants you as a witness, a defendant, or both, is a disaster for the client.

Waiting until the indictment to retain counsel. The window to influence charging decisions, narrow the scope of the conduct alleged, or position for declination closes at indictment. After indictment, you are arguing about plea structure and guideline calculations — not about whether the case gets brought at all.

The investigative window closes long before the indictment. The work that prevents charges or limits exposure happens in the months before the grand jury votes.

The Strategic Defense Approach

Early intervention does three things in a case like this.

First, it can shape the charging document. If we engage the line prosecutors before they finalize the indictment, we can sometimes pull counts off the table, push down loss amount calculations, or knock out money laundering exposure that adds years to any sentence.

Second, it lets us control the narrative on cooperation. The government in these cases needs cooperators to climb the ladder. The first one in the door usually gets the best deal. Showing up early, with a credible proffer plan and a clean record of post-investigation conduct, is what unlocks a 5K1.1 motion or a non-prosecution agreement.

Third, it forces the government to take a more nuanced view of your role. Most of the U.S.-based defendants in cases like the Moscow scheme were not architects. They were operators. Some did not know how deep the fraud went. Some were paid below-market rates and lied to about who they were working for. None of that gets surfaced if you let the prosecutor write the story alone.

Why Timing Matters Now

Three things are converging.

The National Fraud Enforcement Division is staffed and aggressive. SDFL, EDNY, and the Northern District of Texas are all in active investigative posture on telehealth, DME, and pharmacy billing networks. Sentencing benchmarks from the Moscow case give prosecutors political and judicial cover to ask for very long sentences against U.S.-based defendants.

If you have been told you are a witness, received a federal grand jury subpoena, had HHS-OIG agents contact you, or had a pharmacy you owned or managed flagged by a private insurer, the clock has already started.

Facing a Telemedicine or Healthcare Fraud Investigation in Florida?

AMC Defense Law represents pharmacy owners, telehealth doctors, nurse practitioners, marketers, billing operators, and corporate officers in federal healthcare fraud investigations across the Southern and Middle Districts of Florida and nationally. Our practice is built on pre-indictment intervention, controlling the narrative before charges are filed, and aggressive sentencing positioning when charges proceed.

Discretion is the rule. Every consultation is confidential.

Call 561.542.5494 or contact us through amcdefenselaw.com to schedule a confidential case review.

Disclaimer: This article is for general information only and does not constitute legal advice. Reading it does not create an attorney-client relationship. Every case turns on its own facts. If you are under investigation or facing federal charges, speak with a qualified federal criminal defense attorney about your specific situation. Prior outcomes do not guarantee future results.

If you or your loved ones have been arrested or are under federal investigation, call Aaron M. Cohen, 24 hours a day to get help.